Isomorphic Labs
UK-based AI-first drug design and development company
London, UKwww.isomorphiclabs.com ↗
Total raised
€2.3B
€2,349,405,816
Funding rounds
2
Investors
6
distinct backers
Active since
2025-03
latest 2026-05
Funding by year
EUR raised per year · 2026 YTDSignals
High confidenceRaise-next likelihood37
base rate 48% for Series B
- ▼ Raised very recently
- ▲ Up-round momentum
Exit likelihood14
base rate 12% (2+ rounds)
- ▲ €100M+ raised
- ▼ Young (<3y)
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-13 | Series B | €1.8B | Alphabet,CapitalG,GV,Temasek,Thrive Capital,UK Sovereign AI Fund | View deal → |
| 2025-03-31 | Other | €555M | Alphabet,GV,Thrive Capital | View deal → |
AI analysis mentioning Isomorphic Labs
6- Market2026-06-22Six Mega-Rounds Alone Represent €8.31B
- Market2026-06-22UK Dominates Mega-Round Geography With Three of Six Largest Deals
- Report2026-06-19The State of European Tech Funding: €23.3B in 90 Days Points to a Stabilising Market
- Market2026-06-18Top 10 Rounds Absorb Nearly Half of All Capital
- Market2026-06-18Six Rounds Each Exceed €860M, Collectively Representing €8.31B
- Funding2026-06-18UK captures 49% of all recorded capital while holding 25% of deals
AI-generated analysis · every figure traces to cited rounds.